We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
-16.14%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$2.42B
AUM Growth
-$937M
Cap. Flow
-$375M
Cap. Flow %
-15.49%
Top 10 Hldgs %
22.18%
Holding
229
New
12
Increased
31
Reduced
91
Closed
27

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$11.2M
2
BKNG icon
Booking.com
BKNG
+$10.2M
3
ICE icon
Intercontinental Exchange
ICE
+$8.76M
4
DVN icon
Devon Energy
DVN
+$8.49M
5
CTAS icon
Cintas
CTAS
+$8.38M

Sector Composition

Rank Sector Weight
1 Technology 34.41%
2 Industrials 16.87%
3 Financials 15.68%
4 Healthcare 15.08%
5 Consumer Discretionary 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
226
UnitedHealth
UNH
$376B
-4,000
Closed -$2.04M
LHCG
227
DELISTED
LHC Group LLC
LHCG
-8,100
Closed -$1.37M
TWTR
228
DELISTED
Twitter, Inc.
TWTR
-255,000
Closed -$9.87M
BHVN
229
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-185,000
Closed -$21.9M

Similar funds

EULAV Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, EULAV Asset Management held 229 positions worth $2.42B, down 28% from $3.36B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

EULAV Asset Management withdrew a net $375M in Q2 2022, closing 27 positions and reducing 91 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $21.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 34% a quarter earlier, followed by Industrials and Financials.

Against the trend, EULAV Asset Management opened a new position in Advanced Micro Devices worth $9.18M.

  • EULAV Asset Management's largest Q2 2022 buy was Advanced Micro Devices: 120,043 shares worth $9.18M.
  • EULAV Asset Management added most to Intercontinental Exchange in Q2 2022, an estimated $8.76M increase.
  • EULAV Asset Management's biggest Q2 2022 reduction was Mastercard, cutting an estimated $41.7M.
  • EULAV Asset Management fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, selling an estimated $21.9M.
  • EULAV Asset Management's ten largest holdings make up 22% of its $2.42B portfolio in Q2 2022.
  • EULAV Asset Management opened 12 new positions and closed 27 in Q2 2022.
  • EULAV Asset Management's portfolio value fell 28% quarter-over-quarter to $2.42B.

Based on EULAV Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.